Agenda
E-health is a hot topic anticipated to transform healthcare. The mechanisms to fund and pay for e-health solutions are in many countries not as developed as the traditional pathways for drugs, medical devices and hospital care.
In this webinar, Wim Meijer will give an overview of the current state of funding and reimbursement of e-health in The Netherlands and different initiatives to support this.
Speaker
Wim Meijer has over 30 years of experience within the healthcare system. After achieving his degree in Microbiology in 1987, he had several roles within healthcare and healthcare related environments. His first role was as a sales representative in Biotechnology products evolving to a product management role in Medical Disposables for Anesthesia and OR, sales and marketing manager Medical Disposables for Blood collecting organizations in Benelux.
In 2002 he moved to Pharma to become a business development manager for Infliximab, a TNF-α medicine against Rheumatoid Arthritis, Chron’s Disease and Psoriasis. After working with the products he became expert in reimbursement by discussions with Health Insurers. He developed at that time his interest for Market Access. He worked for Shering-Plough and UCB Pharma. He is trained in HTA modeling for Health Economic questions. He has been working with MAQUET for 2 years after a merge with ATRIUM. In this job he was responsible for the Global Market Access and Health Economic challenges for the total Maquet port-folio.
He has joined several working groups within BVMed (Germ), SNITEM (Fr), NICE (UK) and ISPOR and is working in close collaboration with national authorities like NICE, Inek/IQWiQ, HAS, TLV etc. He started his own company WIMENCO beginning of 2016 and worked with several partners in Life Sciences projects.